{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T13:26:01Z","timestamp":1763817961926,"version":"3.45.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prognosis of acute myeloid leukemia is stratified by genetic abnormalities; however, the detection sensitivity varies by method. The KIT D816 mutation is frequently found in core binding factor leukemia and is associated with a poor prognosis. In this study, we aimed to investigate the performance of multiplex droplet digital polymerase chain reaction (ddPCR) for detecting KIT D816 mutations and propose the practical mutation analysis method for clinical laboratory testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the detection limit of ddPCR using mixed probes for HEX-labeled wild-type and FAM-labeled mutations (D816V, D816Y, and D816H) by analyzing plasmid mixtures containing these sequences. We compared the frequency of KIT mutations detected by direct sequencing and ddPCR in 20 patients with core binding factor leukemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multiplex ddPCR successfully discriminated between mutation types based on plot positions on a 2-dimensional map, with a detection limit of 0.1%. The frequency of D816 mutations was 42.5% using ddPCR and 20% using direct sequencing. Most patients with KIT D816 mutation require hematopoietic stem cell transplantation for chimeric gene clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Amplitude-based multiplex ddPCR efficiently provides sensitive and accurate genotyping of KIT D816 and has potential applications for other genetic abnormalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmaf031","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:54:42Z","timestamp":1747817682000},"page":"698-706","source":"Crossref","is-referenced-by-count":0,"title":["<i>KIT<\/i>\n                    amplitude-based multiplex droplet digital polymerase chain reaction outperforms direct sequencing for sensitive\n                    <i>KIT<\/i>\n                    D816 genotyping in core binding factor acute myeloid leukemia"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-8522","authenticated-orcid":false,"given":"Shumpei","family":"Mizuta","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]},{"name":"Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Bandai","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Nishinomiya Hospital , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ueshimo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Bandai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Hiranuma","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Kawata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]},{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tamekane","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center , Hyogo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"2025112208222324700_CIT0001","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia."},{"key":"2025112208222324700_CIT0002","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood."},{"key":"2025112208222324700_CIT0003","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","article-title":"Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11","volume":"4","author":"Ishikawa","year":"2020","journal-title":"Blood Adv."},{"key":"2025112208222324700_CIT0004","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1182\/blood-2012-10-462879","article-title":"Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia","volume":"121","author":"Jourdan","year":"2013","journal-title":"Blood."},{"key":"2025112208222324700_CIT0005","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.leu.2403803","article-title":"Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)","volume":"19","author":"Nanri","year":"2005","journal-title":"Leukemia."},{"key":"2025112208222324700_CIT0006","first-page":"920","article-title":"KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication","volume":"89","author":"Beghini","year":"2004","journal-title":"Haematologica."},{"key":"2025112208222324700_CIT0007","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol."},{"key":"2025112208222324700_CIT0008","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00277-017-3074-y","article-title":"D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations","volume":"96","author":"Yui","year":"2017","journal-title":"Ann Hematol."},{"key":"2025112208222324700_CIT0009","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/biomedicines9080906","article-title":"Clinical utility of liquid biopsy-based actionable mutations detected via ddPCR","volume":"9","author":"Palac\u00edn-Aliana","year":"2021","journal-title":"Biomedicines"},{"key":"2025112208222324700_CIT0010","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.leukres.2018.04.013","article-title":"Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia","volume":"69","author":"Tan","year":"2018","journal-title":"Leuk Res."},{"key":"2025112208222324700_CIT0011","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/bjh.17569","article-title":"Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts","volume":"194","author":"Sasaki","year":"2021","journal-title":"Br J Haematol."},{"key":"2025112208222324700_CIT0012","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u201creal-time\u201d quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe against cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia."},{"key":"2025112208222324700_CIT0013","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/leu.2009.51","article-title":"Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study","volume":"23","author":"Willasch","year":"2009","journal-title":"Leukemia."},{"key":"2025112208222324700_CIT0014","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbt.2023.10.001","article-title":"Droplet digital PCR: a comprehensive tool for genetic analysis and prediction of bispecific antibody assembly during cell line development","volume":"78","author":"Heinzelmann","year":"2023","journal-title":"N Biotechnol"},{"key":"2025112208222324700_CIT0015","doi-asserted-by":"publisher","first-page":"e0049322","DOI":"10.1128\/msphere.00493-22","article-title":"Identifying pathogen and allele type simultaneously in a single well using droplet digital PCR","volume":"8","author":"Notsu","year":"2023","journal-title":"mSphere"},{"key":"2025112208222324700_CIT0016","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12936-021-03659-5","article-title":"Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR","volume":"20","author":"Srisutham","year":"2021","journal-title":"Malar J."},{"key":"2025112208222324700_CIT0017","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41598-024-52983-8","article-title":"Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping","volume":"14","author":"Svetina","year":"2024","journal-title":"Sci Rep."},{"key":"2025112208222324700_CIT0018","doi-asserted-by":"publisher","first-page":"12620","DOI":"10.1038\/s41598-019-49043-x","article-title":"Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA","volume":"9","author":"Rowlands","year":"2019","journal-title":"Sci Rep."},{"key":"2025112208222324700_CIT0019","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/cas.12595","article-title":"Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS\/NRAS) mutation testing in colorectal cancer patients","volume":"106","author":"Taniguchi","year":"2015","journal-title":"Cancer Sci."},{"key":"2025112208222324700_CIT0020","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.1002\/cam4.5512","article-title":"CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma","volume":"12","author":"Yamaguchi","year":"2023","journal-title":"Cancer Med"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/6\/698\/63579697\/lmaf031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/6\/698\/63579697\/lmaf031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T13:22:27Z","timestamp":1763817747000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/56\/6\/698\/8173684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,25]]},"published-print":{"date-parts":[[2025,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaf031","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"type":"print","value":"0007-5027"},{"type":"electronic","value":"1943-7730"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,25]]}}}